Regeneron Pharmaceuticals | REGN - Biaya Penjualan

Harga Saham
686.66
Perubahan Harian
-45.11 -6.16%
Bulanan
-8.36%
Tahunan
14.68%
Q2 Perkiraan
735.49




Biaya Penjualan Perubahan Tanggal
AbbVie USD 4.22B 329M 2026-03
Agenus USD 642K 399K 2025-09
Agios Pharmaceuticals USD 1.32M 560K 2026-03
Alnylam Pharmaceuticals USD 267.72M 67.57M 2025-12
Amgen USD 1.79B 128M 2025-12
Astellas Pharma JPY 129.43B 19.7B 2026-03
AstraZeneca USD -204M 3.48B 2026-03
Biogen USD 797.5M 302M 2026-03
BioMarin Pharmaceutical USD 161.56M 16.62M 2025-12
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Esperion Therapeutics USD 27.85M 13.43M 2025-12
Gilead Sciences USD 1.62B 50M 2025-12
GlaxoSmithKline GBP 1.88B 736M 2026-03
Incyte USD 121.18M 22.18M 2025-12
Ionis Pharmaceuticals USD 3M 5M 2026-03
J&J USD 8.07B 103M 2026-03
Kyowa Hakko Kirin JPY 37.87B 9.67B 2025-12
Merck USD 3.32B 531M 2025-12
Moderna USD 452M 245M 2025-12
Neurocrine Biosciences USD 17.6M 246.4M 2025-12
Novartis USD 3.54B 3M 2025-12
Novartis USD 3.54B 7M 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Puma Biotechnology USD 29.1M 18.44M 2024-09
Regeneron Pharmaceuticals USD 669.4M 84.8M 2026-03
Roche Holding CHF 8.48B 4.61B 2025-12
Sanofi EUR 3.76B 344M 2025-12
Sarepta Therapeutics USD 399.38M 247.93M 2025-12
Teva Pharmaceutical Industries USD 2.01B 46M 2026-03
Ultragenyx Pharmaceutical USD 29M 1.01M 2025-12
United Therapeutics USD 474.7M 373.8M 2025-12
Vertex Pharmaceuticals USD 466M 51.2M 2025-12